13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-03-18 Event 2025-03-16 SEC 0000950170-25-041231 →

FRANCISCO PARTNERS IV, L.P. GoodRx Holdings, Inc. GDRX

Stake: 36.00% Shares: 60,078,184 CUSIP: 38246G108 Class: Class A Common Stock

Item 4 — Purpose of Transaction

Item 4 of the Original 13D is hereby amended to include the following at the end thereof: On March 16, 2025, Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (collectively, the "Selling Stockholders") and the Issuer entered into a Stock Purchase Agreement (the "March 2025 Francisco Partners Stock Purchase Agreement"), pursuant to which the Selling Stockholders agreed to sell an aggregate 10,000,000 Class A Shares to the Issuer for net proceeds of $42,000,000 (the "March 2025 Francisco Partners Repurchase"). The March 2025 Francisco Partners Repurchase is expected to close on March 21, 2025.

Cross-References

Insider Activity (last 365d)
75 transactions
10 buys · 4 sales · 30 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 6.71
6,456,157 shares short · -3.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $1.24M
Point72 Asset Mgmt

Post-Filing Returns · since 2025-03-16 on GDRX

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
0.0%
+180 days
0.0%

Anchor price 3.03 on closest trading day on/after 2025-03-16. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-05-15 Chan Thomas (TC) officer Option exercise 1,252
2026-05-15 McGinnis Christopher A officer Option exercise 44,779
2026-05-15 McGinnis Christopher A officer F 19,726 $2.49 $49K
2026-05-15 Chan Thomas (TC) officer F 638 $2.49 $2K
2026-05-15 Chan Thomas (TC) officer Option exercise 2,637
2026-05-15 Chan Thomas (TC) officer F 1,342 $2.49 $3K
2026-05-15 Chan Thomas (TC) officer Option exercise 1,686
2026-05-15 Chan Thomas (TC) officer F 858 $2.49 $2K
2026-05-11 Chan Thomas (TC) officer Award 54,494
2026-04-15 McGinnis Christopher A officer Award 36,987
2026-04-15 Barnes Wendy Lynn director, officer Option exercise 115,148
2026-04-15 Barnes Wendy Lynn director, officer F 50,021 $2.23 $112K
2026-04-15 Barnes Wendy Lynn director, officer Option exercise 51,177
2026-04-15 Barnes Wendy Lynn director, officer F 22,232 $2.23 $50K
2026-04-15 Barnes Wendy Lynn director, officer Option exercise 110,963
2026-04-15 Barnes Wendy Lynn director, officer F 48,203 $2.23 $107K
2026-04-15 McGinnis Christopher A officer F 10,745 $2.23 $24K
2026-04-15 McGinnis Christopher A officer Option exercise 36,987
2026-03-12 REY-GIRAUD AGNES director Option exercise 192,185 $0.47 $90K
2026-03-12 REY-GIRAUD AGNES director Gift 75,219
2026-03-08 Nabiey Romin officer Option exercise 10,201
2026-03-08 Nabiey Romin officer F 4,201 $2.28 $10K
2026-03-08 Nabiey Romin officer Option exercise 2,233
2026-03-08 Nabiey Romin officer F 920 $2.28 $2K
2026-03-03 McGinnis Christopher A officer Award 443,852
Showing 25 of 75

Other 13D/G Filings on GoodRx Holdings, Inc.

FiledFormFilerStakeShares
2023-10-27 SC Bezdek Trevor view →
2023-10-27 SC Hirsch Douglas Joseph view →
2022-02-14 SC Idea Men, LLC view →
2021-11-05 SC Idea Men, LLC view →
2021-07-16 SC Idea Men, LLC view →

Other Filings by FRANCISCO PARTNERS IV, L.P.

FiledFormIssuerStakeShares
2018-04-27 SC CONNECTURE INC view →
2018-01-04 SC CONNECTURE INC view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →